Tricyclic inhibitors of poly(ADP-ribose) polymerases
View Patent ↗Compounds of the formula below are poly(ADP-ribosyl)transferase (PARP) inhibitors, and are useful as therapeutics in treatment of cancers and the amelioration of the effects of stroke, head trauma, and neurodegenerative disease. As cancer therapeutics, the compounds of the invention may be used, e.g., in combination with cytotoxic agents and/or radiation.
1. A method of preparing a compound of formula I
wherein R 1 is hydrogen or halogen;
R 2 is hydrogen or methyl;
R 3 is:
optionally substituted aryl, alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, heteroaryl; or
—C(O)OR 7 , wherein R 7 is optionally substituted alkyl;
n is 1 or 2;
the method comprising:
a) converting a compound of formula II, wherein R 4 is —(CH 2 ) n NH 2 ; R 5 is —CO 2 CH 3
into a compound of formula III
b) converting the compound of formula III into a compound of formula IV, wherein X is bromine or iodine; and
c) transforming the compound of formula IV into the compound of formula I.
2. The method of claim 1 , wherein the compound of formula II is formed by reduction of a compound of formula V, wherein R 6 is —CH═NOH or —CH═CHNO 2 .
3. The method of claim 2 , wherein the compound of formula V is formed by transformation of the compound of formula VI.
4. The method of claim 3 , wherein the compound of formula VI is formed by Vilsmeier formylation or Friedel-Crafts acylation of the compound of formula VII.
5. The method of claim 1 , wherein the step b) comprises treating the compound of formula III with pyridinium tribromide to form the compound of formula IV.
6. The method of claim 1 , wherein the step c) comprises reacting the compound of formula IV with R 3 B(OH) 2 in the presence of tetrakis(triphenylphosphine)palladium to form the compound of formula I, wherein R 3 is optionally substituted aryl, alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, heteroaryl.
7. The method of claim 1 further comprising reacting the compound of formula I, wherein R 1 is fluorine, R 2 is hydrogen, R 3 is -Ph-CHO, n is 2, with methylamine to form the compound of formula I, wherein R 1 is fluorine, R 2 is hydrogen, R 3 is -Ph-CH 2 —NCH 3 .
8. The method of claim 1 , wherein the step c) comprises reacting the compound of formula IV with Pd/CO/R 7 OH, wherein R 7 is optionally substituted alkyl, to form the compound of formula I, wherein R 3 is —C(O)OR 7 .